The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety, tolerability, pharmacokinetics and preliminary efficacy of MIL93, an anti-Claudin18.2 monoclonal antibody, in patients with advanced solid tumors: A phase 1 clinical study.
 
Jing Huang
No Relationships to Disclose
 
Bo Zhang
No Relationships to Disclose
 
Ying Wang
No Relationships to Disclose
 
Feng Wang
No Relationships to Disclose
 
Shikai Wu
No Relationships to Disclose
 
Yi Zheng
No Relationships to Disclose
 
Jianping Xu
No Relationships to Disclose
 
Dongmei Lan
No Relationships to Disclose
 
Min Wei
No Relationships to Disclose
 
Sijun Liu
No Relationships to Disclose